TRCT
BBNX

Tower Research Capital (TRC)’s Beta Bionics BBNX Stock Holding History

Tower Research Capital (TRC)’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49K Buy
3,129
+138
+5% +$1.64K ﹤0.01% 2753
2026
Q1 		$30K Sell
2,991
-4,483
-60% -$66.3K ﹤0.01% 3167
2025
Q4 		$228K Buy
7,474
+6,209
+491% +$166K 0.01% 1348
2025
Q3 		$25.1K Sell
1,265
-1,119
-47% -$19.7K ﹤0.01% 3095
2025
Q2 		$34.7K Buy
2,384
+1,287
+117% +$18.2K ﹤0.01% 3283
2025
Q1 		$13.4K Buy
+1,097
New +$20.5K ﹤0.01% 3367

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Tower Research Capital (TRC)'s BBNX Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Beta Bionics (BBNX) stake by 4.6% in Q2 2026, buying an estimated $1.64K and bringing the position to 3,129 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #2753.

Tower Research Capital (TRC) first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $228K in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Tower Research Capital (TRC) held 3,129 shares of Beta Bionics worth $49K as of Q2 2026.
  • Tower Research Capital (TRC) bought 138 Beta Bionics shares in Q2 2026, an estimated $1.64K.
  • Beta Bionics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2753 holding.
  • Tower Research Capital (TRC) first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • Tower Research Capital (TRC)'s Beta Bionics position peaked at $228K in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.